ATE362934T1 - Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten - Google Patents

Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten

Info

Publication number
ATE362934T1
ATE362934T1 AT02778547T AT02778547T ATE362934T1 AT E362934 T1 ATE362934 T1 AT E362934T1 AT 02778547 T AT02778547 T AT 02778547T AT 02778547 T AT02778547 T AT 02778547T AT E362934 T1 ATE362934 T1 AT E362934T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
bridged bicyclic
benzodiazepines
vasopressin receptor
vasopressin
Prior art date
Application number
AT02778547T
Other languages
English (en)
Inventor
Alexey Dyatkin
William Hoekstra
Bruce Maryanoff
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE362934T1 publication Critical patent/ATE362934T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT02778547T 2001-10-29 2002-10-11 Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten ATE362934T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34104901P 2001-10-29 2001-10-29

Publications (1)

Publication Number Publication Date
ATE362934T1 true ATE362934T1 (de) 2007-06-15

Family

ID=23336043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02778547T ATE362934T1 (de) 2001-10-29 2002-10-11 Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten

Country Status (12)

Country Link
US (1) US6936604B2 (de)
EP (1) EP1442040B1 (de)
JP (1) JP2005507939A (de)
KR (1) KR20050035173A (de)
CN (1) CN1608068A (de)
AT (1) ATE362934T1 (de)
CA (1) CA2465497A1 (de)
DE (1) DE60220305T2 (de)
ES (1) ES2287326T3 (de)
HU (1) HUP0401722A3 (de)
PL (1) PL370114A1 (de)
WO (1) WO2003037901A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008518915A (ja) * 2004-10-28 2008-06-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ バソプレシンv2受容体アンタゴニストとしての新規な[1,4]ベンゾジアゼピン

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860600A (en) * 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5985869A (en) * 1989-10-20 1999-11-16 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
US5700796A (en) * 1995-01-17 1997-12-23 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AU732214C (en) * 1997-03-31 2001-10-25 Wakamoto Pharmaceutical Co., Ltd. Biphenyl derivatives and drug composition
EP1147115B3 (de) 1999-01-19 2008-12-24 Ortho-McNeil Pharmaceutical, Inc. Tricyclische benzodiazepine als vasopressin antagonisten

Also Published As

Publication number Publication date
PL370114A1 (en) 2005-05-16
WO2003037901A1 (en) 2003-05-08
EP1442040B1 (de) 2007-05-23
KR20050035173A (ko) 2005-04-15
CN1608068A (zh) 2005-04-20
DE60220305T2 (de) 2008-01-17
HUP0401722A3 (en) 2008-07-28
CA2465497A1 (en) 2003-05-08
DE60220305D1 (de) 2007-07-05
EP1442040A1 (de) 2004-08-04
US20030119822A1 (en) 2003-06-26
ES2287326T3 (es) 2007-12-16
HUP0401722A2 (hu) 2005-01-28
JP2005507939A (ja) 2005-03-24
US6936604B2 (en) 2005-08-30

Similar Documents

Publication Publication Date Title
WO2005013894A3 (en) Benzodiazepine cgrp receptor antagonists
IL140622A0 (en) Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
WO2005000807A3 (en) Benzodiazepine cgrp receptor antagonists
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
WO2004092166A3 (en) Cgrp receptor antagonists
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
ATE509019T1 (de) Benzodiazepinspirohydantoine als cgrp- rezeptorantagonisten
WO2004091514A3 (en) Cgrp receptor antagonists
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
ATE423769T1 (de) Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten
DE60222396D1 (de) N-(2-arylethyl) benzylamine als 5-ht6 rezeptor-antagoniste
ATE209207T1 (de) Androgen rezeptor modulator verbindungen und verfahren
MX9702070A (es) Nuevos inhibidores de resorcion osea y antagonistas de receptor de vitronectina.
TR200200408T2 (tr) Yeni spiro bileşikleri
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
ATE280172T1 (de) Isomere kondensierte pyrrolocarbazole und isoindolone
BG103548A (en) Vitronectine receptor antagonists
ATE342253T1 (de) Azabicycloderivate als antagonisten des muscarinischen rezeptors
AU4038000A (en) 4-substituted quinoline derivatives as gaba receptor ligands
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
AU2001285318A1 (en) Use of an aldosterone receptor antagonist to improve cognitive function
WO2002011732A8 (en) Novel bicyclic and tricyclic pyrrolidine derivatives as gnrh antagonists
EA200600688A1 (ru) Арилинденпиридины и арилинденпиримидины и их применение в качестве антагонистов аденозинового рецептора а2а
DE60201892D1 (en) Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
IL145645A0 (en) N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties